Last reviewed · How we verify
Pulmonary tuberculosis
Approved treatments
- Tuberactinomycin N
Enviomycin works by inhibiting bacterial growth and replication. - Cyclorin · Purdue Gmp
- Apacil · Consolidated Midland
- Pyrazinamide · Dava Pharms Inc
- Rifadin · Sanofi Aventis Us
- Isoniazid · Epic Pharma Llc
Isoniazid works by inhibiting the enzyme myeloperoxidase, which is essential for the survival of Mycobacterium tuberculosis. - Priftin · Sanofi
Priftin works by inhibiting the synthesis of mycolic acid, a key component of the Mycobacterium tuberculosis cell wall. - isoniazide · Bridge BioResearch Ltd.
- thioacetazone
- REZIPAS · BRISTOL MYERS SQUIBB
- Myambutol · Kanchan Hlthcare
- Sirturo · Janssen Therap
Sirturo works by blocking the potassium voltage-gated channel subfamily H member 2, which is essential for the survival of Mycobacterium tuberculosis bacteria. - Trecator · Pfizer
- Apacil · Consolidated Midland
- Capastat Sulfate · Epic Pharma Llc
- seromycin · Massachusetts General Hospital
Pipeline
- RIFAMPIN — Phase 2
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pulmonary tuberculosis patent landscape — cliff calendar, originator estates, attackable patents
- Pulmonary tuberculosis treatment landscape brief
- Pulmonary tuberculosis treatment updates RSS
Frequently asked questions about Pulmonary tuberculosis
What drugs treat Pulmonary tuberculosis?
Tracked treatments include Tuberactinomycin N, Cyclorin, Apacil, Pyrazinamide, Rifadin, Isoniazid, Priftin, isoniazide.
What is the treatment for Pulmonary tuberculosis?
Standard treatment for Pulmonary tuberculosis includes Tuberactinomycin N, Cyclorin, Apacil, Pyrazinamide, Rifadin. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Pulmonary tuberculosis?
1 pipeline drugs tracked. Top candidates: RIFAMPIN.
Related
- Treatment landscape: Pulmonary tuberculosis patent cliff · Pulmonary tuberculosis CI report
- Treatment: Tuberactinomycin N
- Treatment: Cyclorin · Purdue Gmp
- Treatment: Apacil · Consolidated Midland
- Treatment: Pyrazinamide · Dava Pharms Inc
- Treatment: Rifadin · Sanofi Aventis Us
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing